SI1593670T1 - S hidroksi substituirani 2-azetidinoni, uporabni kot sredstva za zniĹľevanje holesterola - Google Patents
S hidroksi substituirani 2-azetidinoni, uporabni kot sredstva za zniĹľevanje holesterolaInfo
- Publication number
- SI1593670T1 SI1593670T1 SI200130760T SI200130760T SI1593670T1 SI 1593670 T1 SI1593670 T1 SI 1593670T1 SI 200130760 T SI200130760 T SI 200130760T SI 200130760 T SI200130760 T SI 200130760T SI 1593670 T1 SI1593670 T1 SI 1593670T1
- Authority
- SI
- Slovenia
- Prior art keywords
- hydroxy
- substituted
- hypocholesterolemic agents
- azetidinones useful
- azetidinones
- Prior art date
Links
- -1 Hydroxy-substituted 2-azetidinones Chemical class 0.000 title 1
- 239000003529 anticholesteremic agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25687500P | 2000-12-20 | 2000-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1593670T1 true SI1593670T1 (sl) | 2007-12-31 |
Family
ID=22973953
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200130760T SI1593670T1 (sl) | 2000-12-20 | 2001-12-17 | S hidroksi substituirani 2-azetidinoni, uporabni kot sredstva za zniĹľevanje holesterola |
| SI200130228T SI1347987T1 (sl) | 2000-12-20 | 2001-12-17 | Sladkorni nadomestek 2-acetidionov uporabnih kot hipoholesteroličen agens |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200130228T SI1347987T1 (sl) | 2000-12-20 | 2001-12-17 | Sladkorni nadomestek 2-acetidionov uporabnih kot hipoholesteroličen agens |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20020137690A1 (sl) |
| EP (1) | EP1347987B1 (sl) |
| JP (2) | JP4351842B2 (sl) |
| KR (1) | KR100883461B1 (sl) |
| CN (1) | CN100475829C (sl) |
| AR (1) | AR035611A1 (sl) |
| AT (2) | ATE369334T1 (sl) |
| AU (2) | AU3104902A (sl) |
| BR (1) | BR0116212A (sl) |
| CA (1) | CA2432798C (sl) |
| CY (1) | CY1106912T1 (sl) |
| CZ (1) | CZ302193B6 (sl) |
| DE (2) | DE60106489T2 (sl) |
| DK (2) | DK1593670T3 (sl) |
| EC (1) | ECSP034659A (sl) |
| ES (2) | ES2230385T3 (sl) |
| GE (1) | GEP20053548B (sl) |
| HU (1) | HUP0302269A3 (sl) |
| IL (1) | IL155771A0 (sl) |
| MA (1) | MA26975A1 (sl) |
| MX (1) | MXPA03005671A (sl) |
| MY (1) | MY129148A (sl) |
| NO (2) | NO326981B1 (sl) |
| NZ (1) | NZ525722A (sl) |
| PE (1) | PE20020718A1 (sl) |
| PL (1) | PL208242B1 (sl) |
| PT (2) | PT1593670E (sl) |
| RU (1) | RU2297422C2 (sl) |
| SI (2) | SI1593670T1 (sl) |
| SK (1) | SK286703B6 (sl) |
| TR (1) | TR200402758T4 (sl) |
| TW (1) | TWI316942B (sl) |
| WO (1) | WO2002050090A1 (sl) |
| ZA (1) | ZA200303694B (sl) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| PL205343B1 (pl) | 2001-01-26 | 2010-04-30 | Schering Corp | Zastosowanie inhibitora wchłaniania sterolu |
| ATE348649T1 (de) | 2001-01-26 | 2007-01-15 | Schering Corp | Kombinationen von einem hemmer der sterol- absorption und einem ppar-aktivator zur behandlung von kardiovaskulären indikationen |
| HU230229B1 (hu) | 2001-03-28 | 2015-10-28 | Merck Sharp & Dohme Corp | Azetidinon-intermedier vegyületek enantioszelektiv szintézise |
| CA2460340C (en) | 2001-09-21 | 2011-02-15 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
| AR040588A1 (es) | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
| CA2504878A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorption inhibitors for the treatment of demyelination |
| ES2311806T3 (es) | 2003-03-07 | 2009-02-16 | Schering Corporation | Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| ES2318274T3 (es) | 2003-03-07 | 2009-05-01 | Schering Corporation | Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia. |
| US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| JP2005015434A (ja) * | 2003-06-27 | 2005-01-20 | Kotobuki Seiyaku Kk | 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤 |
| EP1522541A1 (en) * | 2003-10-07 | 2005-04-13 | Lipideon Biotechnology AG | Novel hypocholesterolemic compounds |
| EP1918000A2 (en) | 2003-11-05 | 2008-05-07 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| US7871998B2 (en) | 2003-12-23 | 2011-01-18 | Astrazeneca Ab | Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity |
| EP1699760B1 (en) | 2003-12-23 | 2017-05-17 | Merck Sharp & Dohme Corp. | Anti-hypercholesterolemic compounds |
| GB0329778D0 (en) * | 2003-12-23 | 2004-01-28 | Astrazeneca Ab | Chemical compounds |
| US20060069080A1 (en) * | 2004-09-29 | 2006-03-30 | Veltri Enrico P | Combinations of substituted azetidinones and CB1 antagonists |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| AR054482A1 (es) * | 2005-06-22 | 2007-06-27 | Astrazeneca Ab | Derivados de azetidinona para el tratamiento de hiperlipidemias |
| SA06270191B1 (ar) * | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
| MX2008011418A (es) * | 2006-03-06 | 2008-09-22 | Teva Pharma | Composiciones de ezetimibe. |
| TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
| RU2492175C2 (ru) * | 2007-04-02 | 2013-09-10 | Теракос, Инк. | Бензиловые производные гликозидов и способы их применения |
| US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
| US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| WO2010093752A1 (en) * | 2009-02-11 | 2010-08-19 | Dow Agrosciences Llc | Pesticidal compositions |
| WO2010100255A1 (en) | 2009-03-06 | 2010-09-10 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
| WO2010113175A2 (en) | 2009-04-01 | 2010-10-07 | Matrix Laboratories Ltd | Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe |
| CN101993403B (zh) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | 氮杂环丁酮类化合物及医药应用 |
| KR101102749B1 (ko) * | 2009-11-30 | 2012-01-05 | 최길용 | 곱셈 학습기 |
| KR20150079373A (ko) | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| CN105055404B (zh) * | 2015-08-19 | 2017-07-18 | 四川大学 | Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3595B (en) * | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5627176A (en) * | 1994-03-25 | 1997-05-06 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5633246A (en) * | 1994-11-18 | 1997-05-27 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| ES2175141T3 (es) * | 1995-10-31 | 2002-11-16 | Schering Corp | 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos. |
| US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| AUPQ342599A0 (en) * | 1999-10-14 | 1999-11-04 | University Of Melbourne, The | Conjugates and uses thereof |
-
2001
- 2001-12-17 AU AU3104902A patent/AU3104902A/xx active Pending
- 2001-12-17 AT AT05004699T patent/ATE369334T1/de active
- 2001-12-17 AT AT01991315T patent/ATE279425T1/de active
- 2001-12-17 ES ES01991315T patent/ES2230385T3/es not_active Expired - Lifetime
- 2001-12-17 DK DK05004699T patent/DK1593670T3/da active
- 2001-12-17 SI SI200130760T patent/SI1593670T1/sl unknown
- 2001-12-17 BR BR0116212-8A patent/BR0116212A/pt active Search and Examination
- 2001-12-17 PE PE2001001260A patent/PE20020718A1/es not_active Application Discontinuation
- 2001-12-17 ES ES05004699T patent/ES2287826T3/es not_active Expired - Lifetime
- 2001-12-17 NZ NZ525722A patent/NZ525722A/en not_active IP Right Cessation
- 2001-12-17 CZ CZ20031674A patent/CZ302193B6/cs not_active IP Right Cessation
- 2001-12-17 PT PT05004699T patent/PT1593670E/pt unknown
- 2001-12-17 JP JP2002551983A patent/JP4351842B2/ja not_active Expired - Fee Related
- 2001-12-17 IL IL15577101A patent/IL155771A0/xx not_active IP Right Cessation
- 2001-12-17 SI SI200130228T patent/SI1347987T1/sl unknown
- 2001-12-17 EP EP01991315A patent/EP1347987B1/en not_active Expired - Lifetime
- 2001-12-17 RU RU2003122520/04A patent/RU2297422C2/ru not_active IP Right Cessation
- 2001-12-17 CN CNB01821133XA patent/CN100475829C/zh not_active Expired - Fee Related
- 2001-12-17 AR ARP010105837A patent/AR035611A1/es not_active Application Discontinuation
- 2001-12-17 DE DE60106489T patent/DE60106489T2/de not_active Expired - Lifetime
- 2001-12-17 SK SK770-2003A patent/SK286703B6/sk not_active IP Right Cessation
- 2001-12-17 PT PT01991315T patent/PT1347987E/pt unknown
- 2001-12-17 DE DE60129863T patent/DE60129863T2/de not_active Expired - Lifetime
- 2001-12-17 CA CA002432798A patent/CA2432798C/en not_active Expired - Fee Related
- 2001-12-17 AU AU2002231049A patent/AU2002231049B2/en not_active Ceased
- 2001-12-17 PL PL363237A patent/PL208242B1/pl not_active IP Right Cessation
- 2001-12-17 HU HU0302269A patent/HUP0302269A3/hu unknown
- 2001-12-17 US US10/023,295 patent/US20020137690A1/en not_active Abandoned
- 2001-12-17 KR KR1020037007778A patent/KR100883461B1/ko not_active Expired - Fee Related
- 2001-12-17 DK DK01991315T patent/DK1347987T3/da active
- 2001-12-17 MX MXPA03005671A patent/MXPA03005671A/es active IP Right Grant
- 2001-12-17 WO PCT/US2001/049127 patent/WO2002050090A1/en active Application Filing
- 2001-12-17 TR TR2004/02758T patent/TR200402758T4/xx unknown
- 2001-12-18 TW TW090131349A patent/TWI316942B/zh not_active IP Right Cessation
- 2001-12-19 MY MYPI20015742A patent/MY129148A/en unknown
-
2003
- 2003-05-13 ZA ZA200303694A patent/ZA200303694B/en unknown
- 2003-06-19 EC EC2003004659A patent/ECSP034659A/es unknown
- 2003-06-19 MA MA27205A patent/MA26975A1/fr unknown
- 2003-06-19 NO NO20032806A patent/NO326981B1/no not_active IP Right Cessation
-
2004
- 2004-11-19 GE GEAP8505A patent/GEP20053548B/en unknown
-
2007
- 2007-10-08 CY CY20071101279T patent/CY1106912T1/el unknown
-
2008
- 2008-08-29 NO NO20083737A patent/NO20083737L/no not_active Application Discontinuation
-
2009
- 2009-03-25 JP JP2009075266A patent/JP2009132745A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1593670T1 (sl) | S hidroksi substituirani 2-azetidinoni, uporabni kot sredstva za zniĹľevanje holesterola | |
| AU2002231049A1 (en) | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents | |
| AU7476301A (en) | Novel compounds | |
| EP1276755A4 (en) | NEW COMPOUNDS | |
| AU9261901A (en) | Novel compounds | |
| GB0003019D0 (en) | Novel compounds | |
| EP1255771A4 (en) | NEW COMPOUNDS | |
| EP1292617A4 (en) | Novel compounds | |
| EP1472352A4 (en) | NEW COMPOUNDS | |
| EP1343813A4 (en) | NEW COMPOUNDS | |
| EP1276866A4 (en) | NEW COMPOUNDS | |
| AU4089901A (en) | Panel | |
| GB0004149D0 (en) | Novel compounds | |
| EP1299530A4 (en) | NEW COMPOUNDS | |
| GB0003636D0 (en) | Novel compounds | |
| GB0004196D0 (en) | Novel compounds | |
| GB0002402D0 (en) | Novel compounds | |
| AU2772P (en) | T90-1-0-1 Telopea speciosissima x Telopea oreades | |
| EG22332A (en) | Novel compounds | |
| GB0005818D0 (en) | Hammer | |
| GB0013298D0 (en) | Hammer | |
| GB0002148D0 (en) | Acoustic panel | |
| GB0012359D0 (en) | Numeric internet addressing | |
| HUP0402189A3 (en) | Intermediate compounds | |
| GB0001550D0 (en) | Novel compounds |